# Bupivicain vs Bupivicain Plus Dexamethasone in ESP Block for Post-op Analgesia

> **NCT05277974** · PHASE3 · UNKNOWN · sponsor: **Sheikh Zayed Medical College** · enrollment: 30 (estimated)

## Conditions studied

- Post Operative Pain

## Interventions

- **DRUG:** inj bupivicain

## Key facts

- **NCT ID:** NCT05277974
- **Lead sponsor:** Sheikh Zayed Medical College
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-15
- **Primary completion:** 2022-06-15
- **Final completion:** 2022-07-10
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05277974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05277974, "Bupivicain vs Bupivicain Plus Dexamethasone in ESP Block for Post-op Analgesia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05277974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*